stockrowMerit Medical Systems, Inc.
MMSI Healthcare Medical Instruments & Supplies
Merit Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 11.8% from fiscal 2024.
- Revenue
- +8.35%
- EPS
- +50.5%
- Free cash flow
- +50.2%
- Total debt
- +0.61%
Quarter to September 2026, against a year earlier
Follow MMSI
Alert me
Merit Medical Systems, Inc. (MMSI) EPS (diluted)
Merit Medical Systems, Inc.'s EPS (diluted) for fiscal 2025 was $2.13, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $2.66. Over the past ten years it has ranged from −$0.18 (fiscal 2020) to $2.13 (fiscal 2025) — the current reading is the highest in ten years. EPS (diluted) has risen for 5 consecutive fiscal years. Merit Medical Systems, Inc. ranks 12th of 47 Medical Instruments & Supplies companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $2.13 | 4.93% |
| FY2024 | $2.03 | 25.31% |
| FY2023 | $1.62 | 25.58% |
| FY2022 | $1.29 | 53.57% |
| FY2021 | $0.84 | — |
| FY2020 | −$0.18 | — |
| FY2019 | $0.10 | (87.18%) |
| FY2018 | $0.78 | 41.82% |
| FY2017 | $0.55 | 22.22% |
| FY2016 | $0.45 | (15.09%) |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $0.70 | 7.82% |
| Jun 2026 | $0.65 | (4.41%) |
| Mar 2026 | $0.68 | 7.94% |
| Dec 2025 | $0.63 | 36.96% |
| 43 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| NVST Envista Holdings Corporation compare | $3.92 |
| MMSI Merit Medical Systems, Inc. | $2.66 |
| ICUI ICU Medical, Inc. compare | $2.39 |
| STVN Stevanato Group S.p.A. compare | $0.59 |
| ATRC AtriCure, Inc. compare | $0.30 |
| BLCO Bausch + Lomb Corporation compare | −$0.30 |
| MMED MiniMed Group, Inc. compare | −$0.59 |
| PLSE Pulse Biosciences, Inc compare | −$1.21 |
| TFX Teleflex Incorporated compare | −$23.29 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on MMSI
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement